BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med (Lond) 2021;21:170-3. [PMID: 34001566 DOI: 10.7861/clinmed.2021-0257] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Sulthana S, Chary PS, Bhavana V, Pardhi E, Singh SB, Mehra NK. Development and evaluation emulgel for effective management of the imiquimod-induced psoriasis. Inflammopharmacology 2023. [PMID: 36609718 DOI: 10.1007/s10787-022-01131-7] [Reference Citation Analysis]
2 Pendlebury GA, Oro P, Ludlow K, Merideth D, Haynes W, Shrivastava V. Relevant Dermatoses Among U.S. Military Service Members: An Operational Review of Management Strategies and Telemedicine Utilization. Cureus 2023. [DOI: 10.7759/cureus.33274] [Reference Citation Analysis]
3 Estevinho T, Lé AM, Torres T. Deucravacitinib in the treatment of psoriasis. J Dermatolog Treat 2022;:1-22. [PMID: 36453809 DOI: 10.1080/09546634.2022.2154122] [Reference Citation Analysis]
4 Koppu S, Singh R, Kaur K, Feldman SR. Review of bimekizumab in the treatment of psoriasis. Hum Vaccin Immunother 2022;18:2119767. [PMID: 36094828 DOI: 10.1080/21645515.2022.2119767] [Reference Citation Analysis]
5 Adu SA, Twigg MS, Naughton PJ, Marchant R, Banat IM. Characterisation of cytotoxicity and immunomodulatory effects of glycolipid biosurfactants on human keratinocytes. Appl Microbiol Biotechnol 2022. [DOI: 10.1007/s00253-022-12302-5] [Reference Citation Analysis]
6 Gulliver W, Gooderham MJ, Zhu B, Jossart C, Montmayeur S, Burge R, Reed C. Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program. Dermatol Ther (Heidelb) 2023;13:235-44. [PMID: 36436161 DOI: 10.1007/s13555-022-00853-4] [Reference Citation Analysis]
7 Ahmad Nour Z, Medical Biochemistry and Molecular Biology, Faculty of Medicine,Cairo University, Cairo, Egypt., Elwan Y, Nassar Y, Fathy Elmasry M, Rashed L, Salama Ashour S, Medical Biochemistry and Molecular Biology, Faculty of Medicine,Cairo University, Cairo, Egypt., Medical Biochemistry and Molecular Biology, Faculty of Medicine,Cairo University, Cairo, Egypt., Maha Fathy Elmasry, Dermatology, Faculty of Medicine,Cairo University, Cairo, Egypt., Medical Biochemistry and Molecular Biology, Faculty of Medicine,Cairo University, Cairo, Egypt, Medical Biochemistry and Molecular Biology, Faculty of Medicine,Cairo University, Cairo, Egypt. Possible role of LncRNA MEG3-microRNA-21 and endoplasmic reticulum (ER) stress proteins in the Pathogenesis of Psoriasis Vulgaris. rbmb net 2022;11:367-376. [DOI: 10.52547/rbmb.11.3.367] [Reference Citation Analysis]
8 Shi L, Liu C, Xiong H, Shi D. Elevation of IgE in patients with psoriasis: Is it a paradoxical phenomenon? Front Med (Lausanne) 2022;9:1007892. [PMID: 36314037 DOI: 10.3389/fmed.2022.1007892] [Reference Citation Analysis]
9 Li X, Xing J, Wang F, Li J, Li J, Hou R, Zhang K. The mRNA Expression Profile of Psoriatic Lesion Distinct from Non-Lesion. Clin Cosmet Investig Dermatol 2022;15:2035-43. [PMID: 36193053 DOI: 10.2147/CCID.S385894] [Reference Citation Analysis]
10 Mijaljica D, Spada F, P. Harrison I. Topical Moisturisers for the Management of Psoriasis Vulgaris. Psoriasis - New Research 2022. [DOI: 10.5772/intechopen.101964] [Reference Citation Analysis]
11 Kapoor B, Gulati M, Rani P, Gupta R. Psoriasis: Interplay between dysbiosis and host immune system. Autoimmun Rev 2022;21:103169. [PMID: 35964945 DOI: 10.1016/j.autrev.2022.103169] [Reference Citation Analysis]
12 Mohamed AA, Elhussain E, Fawzy N, Sakr Y, Salah El-Dien M, Abbas AM, Hussein MS, Nassar N, Ezzat O, El-Amir RY, Ibrahim S, Bedair NI. Association of rs1544410 and rs7975232 Polymorphisms and Serum Vitamin D Levels with Psoriasis Susceptibility and Severity: A Case-Control Study in Egyptian Patients. Clin Cosmet Investig Dermatol 2022;15:1271-81. [PMID: 35832487 DOI: 10.2147/CCID.S364267] [Reference Citation Analysis]
13 Huang D, Su L, Zhuang L, Wu J, Zhuang J, Hussein AF. Clinical Value of Vitamin D, Trace Elements, Glucose, and Lipid Metabolism in Diagnosis and Severity Evaluation of Psoriasis. Computational and Mathematical Methods in Medicine 2022;2022:1-8. [DOI: 10.1155/2022/8622435] [Reference Citation Analysis]
14 Kuptsova DG, Radigina TV, Petrichuk SV, Murashkin NN, Khotko AA, Ivanov RA. Assessment of CD4<sup>+</sup> cells subpopulations with the expressing CD39 and CD73 ectonucleotidases in children with psoriasis. Med immunol 2022;24:587-596. [DOI: 10.15789/1563-0625-aoc-2487] [Reference Citation Analysis]
15 Chen Y, Song S, Wang Y, Zhu J, Li X. Potential mechanism of oral baicalin treating psoriasis via suppressing Wnt signaling pathway and inhibiting Th17/IL-17 axis by activating PPARγ. Phytother Res 2022. [PMID: 35778948 DOI: 10.1002/ptr.7546] [Reference Citation Analysis]
16 Shaif M, Kushwaha P, Usmani S, Pandey S. Exploring the potential of nanocarriers in antipsoriatic therapeutics. J Dermatolog Treat 2022;:1-11. [PMID: 35729857 DOI: 10.1080/09546634.2022.2089616] [Reference Citation Analysis]
17 Ivanov RA. Importance and prospects of studying survival of genetically engineered biological therapy for psoriasis in children. Medicinskij alfavit 2022. [DOI: 10.33667/2078-5631-2022-8-80-85] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Funk PJ, Perche PO, Singh R, Kelly KA, Feldman SR. Comparing available JAK inhibitors for treating patients with psoriasis. Expert Review of Clinical Immunology. [DOI: 10.1080/1744666x.2022.2039121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Galluzzo M, Talamonti M, Atzori L, Bardazzi F, Campanati A, Di Cesare A, Diotallevi F, Flori ML, Mugheddu C, Offidani A, Piaserico S, Russo F, Sacchelli L, Bianchi L, Prignano F. Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study. Expert Opinion on Biological Therapy. [DOI: 10.1080/14712598.2022.2029841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Singh R, Koppu S, Perche PO, Feldman SR. The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications. Int J Mol Sci 2021;22:12793. [PMID: 34884596 DOI: 10.3390/ijms222312793] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
21 Bocheńska K, Moskot M, Gabig-Cimińska M. Use of Cytokine Mix-, Imiquimod-, and Serum-Induced Monoculture and Lipopolysaccharide- and Interferon Gamma-Treated Co-Culture to Establish In Vitro Psoriasis-like Inflammation Models. Cells 2021;10:2985. [PMID: 34831208 DOI: 10.3390/cells10112985] [Reference Citation Analysis]
22 Charoenngam N. Vitamin D and Rheumatic Diseases: A Review of Clinical Evidence. Int J Mol Sci 2021;22:10659. [PMID: 34639000 DOI: 10.3390/ijms221910659] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
23 Caputo V, Strafella C, Cosio T, Lanna C, Campione E, Novelli G, Giardina E, Cascella R. Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis. Genes (Basel) 2021;12:1398. [PMID: 34573380 DOI: 10.3390/genes12091398] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
24 Emmanuel A. New wine in old skins. Clin Med (Lond) 2021;21:161. [PMID: 34001563 DOI: 10.7861/clinmed.ed.21.3.1] [Reference Citation Analysis]
25 Merk H, Günther J. Dermatika. Arzneiverordnungs-Report 2021 2021. [DOI: 10.1007/978-3-662-63825-5_24] [Reference Citation Analysis]